These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29786867)

  • 1. Growth hormone-releasing hormone antagonists reduce prostatic enlargement and inflammation in carrageenan-induced chronic prostatitis.
    Popovics P; Cai R; Sha W; Rick FG; Schally AV
    Prostate; 2018 Sep; 78(13):970-980. PubMed ID: 29786867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonists of growth hormone-releasing hormone inhibit proliferation induced by inflammation in prostatic epithelial cells.
    Popovics P; Schally AV; Salgueiro L; Kovacs K; Rick FG
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):1359-1364. PubMed ID: 28123062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonists of growth hormone-releasing hormone inhibit the proliferation of human benign prostatic hyperplasia cells.
    Siejka A; Schally AV; Block NL; Barabutis N
    Prostate; 2010 Jul; 70(10):1087-93. PubMed ID: 20232355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Abi-Chaker A; Krishan A; Szalontay L
    Prostate; 2013 Jun; 73(8):873-83. PubMed ID: 23280565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome.
    Zang L; Tian F; Yao Y; Chen Y; Shen Y; Han M; Meng Z; Fan S; Zhang X; Cai T; Gao Q; Zhang Y; Lu J
    J Cell Mol Med; 2021 Jun; 25(12):5753-5768. PubMed ID: 33982874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
    Liu Y; Shao R; Suo T; Zhu J; Liu E; Wang Y; Miao L; Gao X
    J Ethnopharmacol; 2023 Jun; 309():116354. PubMed ID: 36906158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.
    Funahashi Y; Wang Z; O'Malley KJ; Tyagi P; DeFranco DB; Gingrich JR; Takahashi R; Majima T; Gotoh M; Yoshimura N
    Prostate; 2015 Mar; 75(4):381-9. PubMed ID: 25451715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.
    Funahashi Y; O'Malley KJ; Kawamorita N; Tyagi P; DeFranco DB; Takahashi R; Gotoh M; Wang Z; Yoshimura N
    Prostate; 2014 Apr; 74(4):337-45. PubMed ID: 24446128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
    Rick FG; Szalontay L; Schally AV; Block NL; Nadji M; Szepeshazi K; Vidaurre I; Zarandi M; Kovacs M; Rekasi Z
    J Urol; 2012 Apr; 187(4):1498-504. PubMed ID: 22341819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammation promotes proliferation in the prostatic stroma in rats with experimental autoimmune prostatitis: study for a novel method of inducing benign prostatic hyperplasia in a rat model.
    Zhang M; Luo C; Cui K; Xiong T; Chen Z
    World J Urol; 2020 Nov; 38(11):2933-2943. PubMed ID: 31965289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitargeted protective effect of Abacopteris penangiana against carrageenan-induced chronic prostatitis in rats.
    Yang X; Yuan L; Chen J; Xiong C; Ruan J
    J Ethnopharmacol; 2014; 151(1):343-51. PubMed ID: 24211397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.
    Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C
    Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway.
    Kim HJ; Jin BR; An HJ
    Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin attenuates prostatic hyperplasia caused by inflammation
    Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y
    Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
    Zhou J; Lei Y; Chen J; Zhou X
    Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tight junction protein claudin-1 is downregulated by TGF-β1 via MEK signaling in benign prostatic epithelial cells.
    Wang K; Pascal LE; Li F; Chen W; Dhir R; Balasubramani GK; DeFranco DB; Yoshimura N; He D; Wang Z
    Prostate; 2020 Oct; 80(14):1203-1215. PubMed ID: 32692865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.
    Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X
    Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic Effects of 25-Hydroxyvitamin D on the Pathological Process of Benign Prostatic Hyperplasia: An In Vitro Evidence.
    Chen Y; Xu H; Liu C; Gu M; Chen Q; Zhan M; Wang Z
    Dis Markers; 2021; 2021():4029470. PubMed ID: 34671434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.